MHRA launch new learning package on SSRI antidepressants

shutterstock_82444480

If you are a doctor, nurse or pharmacist involved in the care of patients with depression, you may like to take this self-directed learning module on selective serotonin reuptake inhibitors (SSRI) antidepressants produced by the Medicines and Healthcare products Regulatory Agency (MHRA).

The free online training outlines the key risks of this important class of medicines. For each adverse effect, the package outlines:

  • The main features of the adverse effect
  • Factors that increase the risk
  • How the risk can be reduced
  • Specific treatment for the adverse effect

A self-assessment exercise, together with full feedback, complements the learning material.

MHRA say that clinicians starting out in psychiatry will find it especially valuable.

SSRI learning module. Medicines and Healthcare products Regulatory Agency, 24 Nov 2011.

Share on Facebook Tweet this on Twitter Share on LinkedIn Share on Google+
Mark as read
Create a personal elf note about this blog
Andre Tomlin

Andre Tomlin

André Tomlin is an Information Scientist with 20 years experience working in evidence-based healthcare. He's worked in the NHS, for Oxford University and since 2002 as Managing Director of Minervation Ltd, a consultancy company who do clever digital stuff for charities, universities and the public sector. Most recently André has been the driving force behind the Mental Elf and the National Elf Service; an innovative digital platform that helps professionals keep up to date with simple, clear and engaging summaries of evidence-based research. André is a Trustee at the Centre for Mental Health and an Honorary Research Fellow at University College London Division of Psychiatry. He lives in Bristol with his wife, dog and three little elflings.

More posts - Website

Follow me here –